About UsProductsNewsClinical TrialCorporate RelationsResources


Corporate Mission Statement

CEO Message

Board of Directors

Key Employees

Corporate History




Ash Medical Systems, Inc (“AMS”) founded by Dr. Stephen R. Ash and Robert B. Truitt to develop a home hemodialysis system

AMS creates spin off company, HemoCleanse, Inc (“HCI”), to develop new liver dialysis system and technology




HemoCleanse, Inc purchases AMS to consolidate assets and develop vascular access technologies

HemoCleanse, Inc creates spin off company, Renal Solutions, Inc, ("RSI") to commercialize home hemodialysis system




AMS is renamed Ash Access Technology, Inc. and is spun off from HemoCleanse, Inc. in order to commercialize vascular access technologies

Ash Access Technology, Inc. begins pivotal clinical trial on Zuragen™




Received FDA approval for Centros™. Strategic partnership for Centros™ initiated with AngioDynamics, Inc.

AZEPTIC Trial completed for Zuragen™ Injection. Human "pilot" studies completed with ZuraPrep™



Product Development:

  • Column Disc
    peritoneal dialysis (PD) catheter
  • Y-Tech
    peritoneoscopic system PD
  • Cal-Carb HD
    oral calcium carbonate, phosphate binder
  • SmartChart
    electronic clinical notation system
  • CFC
    capillary filtrate collector, sub-q catheter
  • BioLogic-HD
    home hemodialysis system
  • BioLogic DT
    liver dialysis machine
  • ThermoChem-HT
    intraperitoneal hyperthermia system
  • Ash Advantage
    peritoneal dialysis (PD) catheter
  • Ash Split-Cath
    chronic tunneled hemodialysis catheter
  • DuoSplit
    acute hemodialysis catheter
  • HC-10
    high flow single lumen catheter for liver dialysis
  • Allient
    home hemodialysis system (by spin-off RSI)
  • Centros™
    chronic tunneled hemodialysis catheter (strategic commercial partnership with Angiodynamics, Inc.)